SCHEMBL4416032

SCHEMBL4416032

CCn1cnc(C(=O)Nc2ccc(Cl)cn2)c1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.55
NPC1 O15118 7/20 0.55
SMN1; SMN2 Q16637 5/20 0.55
TSHR P16473 3/20 0.55
SCN9A Q15858 1/20 0.49
TP53 P04637 2/20 0.49
MAPT P10636 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
NFKB1 P19838 2/20 0.49
NFKB2 Q00653 2/20 0.49
RELA Q04206 2/20 0.49
MAPK1 P28482 2/20 0.49
PTK2 Q05397 1/20 0.49
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
CASP3 P42574 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3190859 0.86 SCN9A (0.56) RAB9ANPC1TSHRSCN9ATP53
SCHEMBL4435799 0.78 KCNQ3 (0.48) RAB9ASMN1; SMN2SCN9AMAPTL3MBTL1
SCHEMBL4411279 0.76 ALOX15 (0.43) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL28764679 0.72 L3MBTL1 (0.66) RAB9ANPC1SMN1; SMN2TSHRTP53
SCHEMBL29837506 0.72 L3MBTL1 (0.66) RAB9ANPC1SMN1; SMN2TSHRTP53
SCHEMBL6772756 0.72 GRM5 (0.62) RAB9ANPC1SMN1; SMN2TSHRTP53
SCHEMBL7372031 0.71 SMN1; SMN2 (0.64) RAB9ANPC1SMN1; SMN2TSHRSCN9A
SCHEMBL4272301 0.71 GRM5 (0.61) RAB9ANPC1SMN1; SMN2TSHRSCN9A
SCHEMBL3185799 0.71 SCN9A (0.50) RAB9ANPC1SMN1; SMN2TSHRSCN9A
SCHEMBL3901503 0.70 GRM4 (0.60) RAB9ANPC1SMN1; SMN2TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009121036-A2 SUBSTITUTED ARYL PYRIMIDINONE DERIVATIVES NEUROGEN CORPORATION (US) 2009-10-01 WO disclosed